Clinical Trial Update: Risperidone Augmentation in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating risperidone augmentation in patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED